Compare CORT & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | EXLS |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 6.6B |
| IPO Year | N/A | 2006 |
| Metric | CORT | EXLS |
|---|---|---|
| Price | $83.09 | $43.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $130.20 | $54.50 |
| AVG Volume (30 Days) | 965.7K | ★ 1.2M |
| Earning Date | 11-04-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.94 |
| EPS | 0.87 | ★ 1.48 |
| Revenue | $741,172,000.00 | ★ $2,026,490,000.00 |
| Revenue This Year | $23.79 | $15.27 |
| Revenue Next Year | $40.97 | $11.33 |
| P/E Ratio | $95.90 | ★ $29.12 |
| Revenue Growth | ★ 17.92 | 14.43 |
| 52 Week Low | $49.00 | $37.30 |
| 52 Week High | $117.33 | $52.43 |
| Indicator | CORT | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 71.45 |
| Support Level | $78.07 | $41.00 |
| Resistance Level | $89.00 | $42.03 |
| Average True Range (ATR) | 3.58 | 0.74 |
| MACD | -0.28 | 0.33 |
| Stochastic Oscillator | 59.52 | 97.58 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.